- Category
- Micro (2024-25)
- Udyam number
- UDYAM-BR-26-0036916

Aslay Biogen Private Limited
About Aslay Biogen Private Limited
Data last updated:
Aslay Biogen Private Limited is a private limited company based in Patna, Bihar, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U74999BR2018PTC037819. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹11 Lakh. It is led by directors including Anuradha (Managing Director) and Shambhu Nath Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Indu Niwas Plot No – 1705 Aaditya Nagar Bv College Ps – New Airport Jagdeo Path Baily Road, Patna, Bihar, India – 800014.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.76 Cr. For the same year it recorded a net profit of ₹69,630 (net margin 0.4%) and EBITDA of ₹1.34 Lakh (EBITDA margin 0.8%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 33% over five years.
As per MCA filings, the company has open charges of ₹30 Lakh on record.
Aslay Biogen Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-26-0036916).
Company details
Recognitions & Rankings of Aslay Biogen
Contact details
Aslay Biogen Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressIndu Niwas Plot No – 1705 Aaditya Nagar Bv College Ps – New Airport Jagdeo Path Baily Road, Patna, Bihar, India – 800014
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Aslay Biogen Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Aslay Biogen Private Limited
FY 2025 filings availableAslay Biogen Private Limited reported revenue of ₹1.76 Cr for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 33% over five years. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.34 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹69,630 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aslay Biogen Private Limited, buy the company report.
Board of directors of Aslay Biogen Private Limited
Aslay Biogen has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shambhu Nath Sharma | Director | 12 Apr 2018 | 8 Years 6 Months | Current |
| Anuradha | Managing Director | 12 Apr 2018 | 8 Years 6 Months | Current |
| Amit Kumar Sinha | Director | 28 Jan 2019 | 7 Years 9 Months | Current |
Peer comparison
Aslay Biogen Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alak Healthcare Private Limited | ₹1.77 Cr (FY 2024) | 393.0% | Jetpur, Gujarat, India | |||
| Nutrite Healthcare Private Limited | ₹1.76 Cr (FY 2024) | 534486.0% | Mumbai, Maharashtra, India | |||
| Aslay Biogen Private Limitedthis company | ₹1.76 Cr (FY 2025) | ₹69,630 | 0.4% | Patna, Bihar, India | ||
| Xion Pharmaceuticals Private Limited | ₹1.76 Cr (FY 2025) | -1.0% | Pune, Maharashtra, India | |||
| Meditrina Life Sciences Private Limited | ₹1.75 Cr (FY 2025) | 23.0% | Nashik, Maharashtra, India |
To see the full peer comparison of Aslay Biogen Private Limited, buy the company report.
Auditor
Aslay Biogen Private Limited is audited by DUSHYANT KUMAR & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DUSHYANT KUMAR & CO | FY 2019 | 020157C |
Shareholding
The shareholding of Aslay Biogen Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Aslay Biogen Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Nov 2025 | 101210178 | Others | ₹30 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Aslay Biogen Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aslay Biogen Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aslay Biogen has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Aslay Biogen Private Limited, buy the company report.
Recent activity
Aslay Biogen Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Amit Kumar Sinha was appointed as Director on 28 Jan 2019.
Frequently asked questions
Aslay Biogen is an active private limited company based in Patna, Bihar, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 April 2018 (8+ years old) and is registered under CIN U74999BR2018PTC037819.
Aslay Biogen has 3 current directors:
- Anuradha - Managing Director
- Shambhu Nath Sharma - Director
- Amit Kumar Sinha - Director
The latest financial statements of Aslay Biogen on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
No. Aslay Biogen has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Aslay Biogen is U74999BR2018PTC037819. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aslay Biogen was incorporated on 12 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Aslay Biogen by revenue are Alak Healthcare Private Limited, Nutrite Healthcare Private Limited, Xion Pharmaceuticals Private Limited, Meditrina Life Sciences Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Amit Kumar Sinha was appointed as Director on 28 Jan 2019. Anuradha was appointed as Managing Director on 12 Apr 2018. Shambhu Nath Sharma was appointed as Director on 12 Apr 2018.
Yes, Aslay Biogen is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-26-0036916).
The registered office of Aslay Biogen is at Indu Niwas Plot No – 1705 Aaditya Nagar Bv College Ps – New Airport Jagdeo Path Baily Road, Patna, Bihar, India – 800014.
Aslay Biogen operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

